Cargando…

Utility of adjuvant whole abdominal radiation therapy in ovarian clear cell cancer (OCCC): a pragmatic cohort study of women with classic immuno-phenotypic signature

BACKGROUND: To evaluate the initial experience and clinical utility of first-line adjuvant intensity-modulated whole abdominal radiation therapy (WART) in women with ovarian clear cell cancer (OCCC) referred to an academic center. METHODS: Progression-free and overall survival was analyzed in a prag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevens, Mark J., West, Simon, Gard, Gregory, Renaud, Christopher, Nevell, David, Roderick, Stephanie, Le, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866446/ https://www.ncbi.nlm.nih.gov/pubmed/33549120 http://dx.doi.org/10.1186/s13014-021-01750-4

Ejemplares similares

Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution
por: Shi, Yuying, et al.
Publicado: (2021)

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options
por: Elvin, Julia A., et al.
Publicado: (2017)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

Activation of tonsil dendritic cells with immuno-adjuvants
por: Polak, Marta E, et al.
Publicado: (2008)

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
por: Verdura, Sara, et al.
Publicado: (2019)

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
por: Cognigni, Valeria, et al.
Publicado: (2021)

Transcriptomic characterization of classical monocytes highlights the involvement of immuno-inflammation in bone erosion in Rheumatoid Arthritis
por: Sales, Lucas Peixoto, et al.
Publicado: (2023)

HMGB1 and Cord Blood: Its Role as Immuno-Adjuvant Factor in Innate Immunity
por: Ciucci, Alessandra, et al.
Publicado: (2011)

Efficient gene expression signature for a breast cancer immuno-subtype
por: Galili, Ben, et al.
Publicado: (2021)

Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2007)

ClearSeeAlpha: Advanced Optical Clearing for Whole-Plant Imaging
por: Kurihara, Daisuke, et al.
Publicado: (2021)

EZ Clear for simple, rapid, and robust mouse whole organ clearing
por: Hsu, Chih-Wei, et al.
Publicado: (2022)

Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity
por: Liu, Lisha, et al.
Publicado: (2018)

Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma
por: Batai, Ken, et al.
Publicado: (2018)

A pragmatic, evidence-based approach to coding for abdominal wall reconstruction
Publicado: (2021)

Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials
por: Donovan, Jenny L, et al.
Publicado: (2014)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Transformation of Abdominal Wall Endometriosis to Clear Cell Carcinoma
por: Ruiz, Maria Paula, et al.
Publicado: (2015)

Security of quantum digital signatures for classical messages
por: Wang, Tian-Yin, et al.
Publicado: (2015)

MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
por: Secchiari, Florencia, et al.
Publicado: (2022)

ClearSee: a rapid optical clearing reagent for whole-plant fluorescence imaging
por: Kurihara, Daisuke, et al.
Publicado: (2015)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Hijacking Sexual Immuno-Privilege in GBM—An Immuno-Evasion Strategy
por: Sharpe, Martyn A., et al.
Publicado: (2021)

The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell Carcinoma
por: Berg, Stephanie A., et al.
Publicado: (2022)

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients
por: Adamik, Juraj, et al.
Publicado: (2023)

Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience
por: Liu, Shiru L., et al.
Publicado: (2019)

Clear Cell Adenocarcinoma Arising from Abdominal Wall Endometriosis
por: Achach, Thouraya, et al.
Publicado: (2008)

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Frequency of abdominal wall hernias: is classical teaching out of date?
por: Dabbas, Natalie, et al.
Publicado: (2011)

CSF-diverting shunts: Implications for abdominal and pelvic surgeons; a review and pragmatic overview
por: Goel, Aimee, et al.
Publicado: (2019)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
por: Rousset-Rouviere, Sandrine, et al.
Publicado: (2021)

Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy
por: Walters, Adam A., et al.
Publicado: (2020)

Fueling sentinel node via reshaping cytotoxic T lymphocytes with a flex-patch for post-operative immuno-adjuvant therapy
por: Li, Bei, et al.
Publicado: (2023)

Can the first quadrupole of a classical final focus system clear the disrupted beam?
por: Schnell, Wolfgang
Publicado: (1986)

Immuno-Electrophoretic Analysis
por: Wood, Harrison F.
Publicado: (1965)

EMT in immuno-resistance
por: Terry, Stéphane, et al.
Publicado: (2015)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration
por: Lawal, Bashir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_prfnfsjblnlh114uer6knmje09